This Week in BMC Cancer | GenomeWeb

This Week in BMC Cancer


In BMC Cancer this week, researchers in Kansas and Oklahoma describe the development and characterization of a novel C-terminal inhibitor of heat shock protein 90 in prostate cancer cells. Hsp90 has been shown to be over-expressed in a number of cancers, the authors write. For this study, the team used PC3-MM2 and LNCaP-LN3 prostate cancer cell lines to test an Hsp90 inhibitor, KU174.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In PNAS this week: miR-515 levels higher in women with preeclampsia, horizontal gene transfer in parasitic plants, and more.

A cancer researcher retracts 19 articles from one journal for image manipulation, according to Retraction Watch.

Precision medicine has to consider context in addition to genetic mutations in cancer treatment, Medscape reports.

Genomics may help the Cavendish banana from succumbing to fungal infections, a trio of researchers writes at the Conversation.